BFC Planning’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$784 Hold
305
– – ﹤0.01% 3216
2026
Q2
$988 Buy
305
+120
+65% +$351 ﹤0.01% 3154
2026
Q1
$457 Hold
185
– – ﹤0.01% 2867
2025
Q4
$379 Hold
185
– – ﹤0.01% 2968
2025
Q3
$642 Hold
185
– – ﹤0.01% 2711
2025
Q2
$407 Hold
185
– – ﹤0.01% 2565
2025
Q1
$215 Buy
+185
New +$272 ﹤0.01% 2579

Other funds holding EDIT

BFC Planning's EDIT Position: Q3 2026 in Review

BFC Planning held its Editas Medicine (EDIT) position steady in Q3 2026 at 305 shares worth $784. The position accounts for ﹤0.01% of the portfolio, ranked #3216.

BFC Planning first reported a position in EDIT in Q1 2025 and has held it in 7 quarters since. The position peaked at $988 in Q2 2026. 162 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

  • BFC Planning held 305 shares of Editas Medicine worth $784 as of Q3 2026.
  • BFC Planning left its Editas Medicine share count unchanged in Q3 2026.
  • Editas Medicine made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3216 holding.
  • BFC Planning first reported a position in Editas Medicine in Q1 2025 and has held it in 7 quarters since.
  • BFC Planning's Editas Medicine position peaked at $988 in Q2 2026.
  • 162 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.